NCT02145091View on ClinicalTrials.gov

Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 26, 2019

Study Completion Date

December 26, 2019

Conditions
Healthy
Interventions
DRUG

Moderately-high dose of psilocybin

Oral dose of a moderately-high dose of psilocybin.

DRUG

Moderately-low dose of psilocybin

Oral dose of a moderately-low dose of psilocybin.

DRUG

Very-low dose of psilocybin

Oral dose of a very-low dose of psilocybin.

DRUG

Placebo

An oral placebo (lactose pill).

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02145091 - Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators | Biotech Hunter | Biotech Hunter